UBS Group’s BioRestorative Therapies BRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5 | Sell |
3
-8,343
| -100% | -$13.9K | ﹤0.01% | 8847 |
|
|
2025
Q1 | $14.9K | Sell |
8,346
-7,951
| -49% | -$14.2K | ﹤0.01% | 7100 |
|
|
2024
Q4 | $23.3K | Buy |
16,297
+15,604
| +2,252% | +$22.3K | ﹤0.01% | 6549 |
|
|
2024
Q3 | $1.21K | Sell |
693
-27,120
| -98% | -$47.2K | ﹤0.01% | 7472 |
|
|
2024
Q2 | $56.5K | Buy |
27,813
+26,973
| +3,211% | +$54.8K | ﹤0.01% | 5461 |
|
|
2024
Q1 | $1.16K | Buy |
840
+746
| +794% | +$1.03K | ﹤0.01% | 7037 |
|
|
2023
Q4 | $164 | Buy |
94
+93
| +9,300% | +$162 | ﹤0.01% | 7638 |
|
|
2023
Q3 | $2 | Sell |
1
-3,078
| -100% | -$6.16K | ﹤0.01% | 8195 |
|
|
2023
Q2 | $13.6K | Buy |
3,079
+1,484
| +93% | +$6.54K | ﹤0.01% | 5962 |
|
|
2023
Q1 | $5.42K | Buy |
1,595
+1,594
| +159,400% | +$5.42K | ﹤0.01% | 6944 |
|
|
2022
Q4 | $3 | Sell |
1
-1,566
| -100% | -$4.7K | ﹤0.01% | 9431 |
|
|
2022
Q3 | $5K | Buy |
1,567
+1,068
| +214% | +$3.41K | ﹤0.01% | 8064 |
|
|
2022
Q2 | $1K | Buy |
499
+498
| +49,800% | +$998 | ﹤0.01% | 8779 |
|
|
2022
Q1 | $0 | Sell |
1
-303
| -100% | – | ﹤0.01% | 9177 |
|
|
2021
Q4 | $1K | Buy |
+304
| New | +$1K | ﹤0.01% | 8825 |
|